BCM
MDCO

Bluefin Capital Management’s Medicines Co MDCO Stock Holding History

Bluefin Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-870,200
Closed -$21K – 756
2019
Q4 		$21K Buy
870,200
+494,800
+132% +$33M ﹤0.01% 506
2019
Q3 		$563K Buy
375,400
+119,600
+47% +$4.77M 0.08% 165
2019
Q2 		$550K Buy
+255,800
New +$8.35M 0.08% 137

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bluefin Capital Management's MDCO Position: Q4 2019 in Review

Bluefin Capital Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 165,624 shares — an estimated $11M sold.

Bluefin Capital Management first reported a position in MDCO in Q2 2017 and held it in 2 quarters. The position peaked at $8.28M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Bluefin Capital Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Bluefin Capital Management sold 165,624 Medicines Co shares in Q4 2019, an estimated $11M.
  • Bluefin Capital Management first reported a position in Medicines Co in Q2 2017 and held it in 2 quarters.
  • Bluefin Capital Management's Medicines Co position peaked at $8.28M in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Bluefin Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.